Cabometyx study ends early after researchers see 'dramatic' benefits in neuroendocrine tumors, Exelixis says - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 24, 2023 at 4:57 PM in business No comments 22
Bayer survey reveals deep-seated fears of Americans around cancer as pharma looks to plug education gapBayer survey reveals deep-seated fears of Americans around cancer as pharma looks to plug education gap - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 22, 2023 at 2:22 PM in health No comments 36
FDA approves Pfizer's Abrysvo for pregnancy to protect babies - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 22, 2023 at 3:17 PM in health No comments 58
After Regeneron scores FDA nod for high-dose Eylea, it’s game on in showdown with Roche’s VabysmoFDA approves Regeneron's HD Eylea, triggering battle with Roche - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 21, 2023 at 3:01 PM in business No comments 61
Moderna present strong preliminary data for updated COVID shot - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 18, 2023 at 3:06 PM in business No comments 10
On blockbuster mission, Merck says Welireg hit endpoint in renal cell carcinoma trial - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 18, 2023 at 3:12 PM in business No comments 38
MSF calls out GSK's ViiV for nondisclosure clauses in contract - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 17, 2023 at 6:54 PM in health No comments 28
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmaciesGSK says RSV shot Arexvy has arrived at major US pharmacies - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 17, 2023 at 2:55 PM in health No comments 30
The Ad Council teams up with the Alzheimer's Association for Hispanic dementia awareness push - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 16, 2023 at 2:42 PM in health No comments 13
AstraZeneca hit with FDA warning letter over 'misleading' Breztri efficacy claims - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 16, 2023 at 9:28 AM in business No comments 49
Pfizer unveils potential cost-cutting measure on low COVID sales - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 1, 2023 at 5:45 PM in business No comments 60
Merck still eyeing M&A and has plenty of firepower to execute it - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on August 1, 2023 at 3:25 PM in business No comments 1
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancerGSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 31, 2023 at 6:42 PM in business No comments 17
Apellis attempts to clear the air around Syfovre safety as eye drug launch gains steam - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 31, 2023 at 2:22 PM in business No comments 42
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 28, 2023 at 3:17 PM in business No comments 9
AstraZeneca forecasts stronger China sales as CEO tries to clear the air on spinoff reportAstraZeneca forecasts stronger China sales as CEO tries to clear the air on spinoff report - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 28, 2023 at 3:06 PM in business No comments 40
Takeda hypes up dengue vaccine launch progress as Vyvanse generics loom - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 27, 2023 at 5:38 PM in health No comments 63
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 25, 2023 at 1:32 PM in health No comments 40
GSK’s Arexvy to lead new RSV vaccines sales race with Moderna a close second: reportGSK's Arexvy to lead new RSV vaccines sales race with Moderna a close second: report - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 24, 2023 at 2:44 PM in health No comments 60
GSK-funded report on adult vaccination rates finds major global declines in recent years - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 19, 2023 at 6:59 PM in health No comments 34
Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyondWeight-loss drug shortage expands to Novo's Saxenda - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 19, 2023 at 3:24 PM in health No comments 12
Novartis to buy back $15B in shares despite Entresto setback - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 18, 2023 at 3:05 PM in business No comments 1
Oh doctor, J&J sues physicians who say baby powder causes cancer - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 14, 2023 at 2:30 PM in business No comments 20
Merck applies more pressure against IRA, asking for decision without trial in fight with US government - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 12, 2023 at 3:14 PM in business No comments 16
EMA will monitor suicide risk in Novo Nordisk's GLP-1 products - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 10, 2023 at 3:11 PM in business No comments 53